Sanjivani Paranteral Ltd 13 Nov 2026 12:00 AM
Sanjivani Paranteral Ltd consolidated sales up 6.25% on year in Q2FY2027, net profit surged by 66.67%,
Sanjivani Paranteral Ltd share price slipped 3.30% to Rs 172.65. The Company`s net profit saw a strong growth of 66.67% to Rs 4.15 crore, while revenue from operations improved marginally 6.25% to Rs 25.33 crore in Q2FY27 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, easing 6.40%. It has marginally improved by 2.89% over last one week and moved up slightly by 6.37% in last one month while the market capitalization of Sanjivani Paranteral Ltd has eased by 2.32% and 11.73% in the same period respectively. Profit before tax (PBT) of Sanjivani Paranteral Ltd stood at Rs 5.53 crore in Q2 FY27, expanding by 152.51% year-on-year, and surging by 66.57% quarter-on-quarter. EBITDA came in at Rs 6 crore, rallying 205.26% YoY and jumping 58.71% sequentially. Total expenses marginally dropped 3.99% to Rs 19.51 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 12.09 crore, slumping by 22.85% YoY, while employee benefits expense was at Rs 2.47 crore, ticking higher by 5.11% YoY. For FY26, revenue from operations eased 2.04% to Rs 68.67 crore, while net profit declined by 17.31% to Rs 6.69 crore, compared to previous FY. EBITDA witnessed a strong improvement of 873% to Rs 9.22 crore, and PBT saw a marginal contraction of 9.28% to Rs 9.39 crore compared to previous FY. The company`s consolidated net cash flow from operating activities stood at Rs 0.03 crore in FY26, as against Rs 12.4 crore in FY25. Sanjivani Paranteral Ltd crashed 14.02% in last one year, underperforming the benchmark BSE Sensex which has softened by 3.03% during the same period.
Sanjivani Paranteral Ltd 12 Nov 2026 12:00 AM
Sanjivani Paranteral Ltd consolidated sales up 6.25% on year in Q2FY2027, net profit surged by 66.67%,
Sanjivani Paranteral Ltd share price ticked higher by 2.70% to Rs 178.55 after the company`s net profit soared by 66.67% to Rs 4.15 crore, while revenue from operations slightly gained 6.25% to Rs 25.33 crore in Q2FY27 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, gaining 5.84%. It has marginally improved by 3.49% over last one week and gained upto 6.26% in last one month while the market capitalization of Sanjivani Paranteral Ltd has inched up 1.25% and 8.71% in the same period respectively. Profit before tax (PBT) of Sanjivani Paranteral Ltd stood at Rs 5.53 crore in Q2 FY27, surging by 152.51% year-on-year, and expanding by 66.57% quarter-on-quarter. EBITDA came in at Rs 6 crore, jumping 205.26% YoY and rallying 58.71% sequentially. Total expenses slightly declined by 3.99% to Rs 19.51 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 12.09 crore, registering a fall of 22.85% YoY, while employee benefits expense was at Rs 2.47 crore, ticking higher by 5.11% YoY. For FY26, revenue from operations eased 2.04% to Rs 68.67 crore, while net profit fell 17.31% to Rs 6.69 crore, compared to previous FY. EBITDA witnessed a strong improvement of 873% to Rs 9.22 crore, and PBT saw a marginal contraction of 9.28% to Rs 9.39 crore compared to previous FY. The company`s consolidated net cash flow from operating activities stood at Rs 0.03 crore in FY26, as against Rs 12.4 crore in FY25. Sanjivani Paranteral Ltd crashed 12.77% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.37% during the same period.
Sanjivani Paranteral Ltd 28 Sep 2026 12:00 AM
Sanjivani Paranteral Limited closes securities trading window ahead of quarterly results,
Sanjivani Paranteral Limited informed the BSE Limited that the trading window for dealing in the company`s securities will be closed from July 1, 2026, for consideration of the un-audited financial results for the second quarter ended September 30, 2026, and will reopen 48 hours after the results become generally available to the public.
Sanjivani Paranteral Ltd 25 Aug 2026 12:00 AM
Shareholders can vote electronically via InstaVote, contacting NSDL or CDSL for assistance,
Shareholders are instructed to cast their votes electronically via the InstaVote platform, accessible at [https://instavote.linkintime.co.in/](https://instavote.linkintime.co.in/), utilizing either direct vote entry or file upload methods. Individual shareholders holding securities in demat mode should contact NSDL ([email protected] or 022 - 4886 7000) or CDSL ([email protected] or 1800 22 55 33) for assistance with user ID or password recovery. Shareholders holding securities in physical mode or corporate shareholders experiencing issues with InstaVote can reach out to [email protected] or 022 – 4918 6000. Shareholders are reminded to keep their passwords confidential and that once a vote is cast, it cannot be altered.
Sanjivani Paranteral Ltd 25 Aug 2026 12:00 AM
Shareholders can vote electronically via NSDL, CDSL portals, or INSTAVOTE platform,
Shareholders have multiple options for electronic voting, as detailed in the company’s annual report. Individual shareholders with Demat accounts can vote through the NSDL portal, contacting the helpdesk at [email protected] or 022 - 4886 7000, or the CDSL portal, reaching the helpdesk at [email protected] or 1800 22 55 33. Shareholders holding physical shares or those with Demat accounts utilizing INSTAVOTE can access the platform at instavote.linkintime.co.in, while corporate shareholders have the option to enter votes directly or upload a prepared file, requiring a scanned copy of a Board resolution or Power of Attorney. General helpdesk support for INSTAVOTE is available at [email protected] or 022 – 4918 6000.
Subscribe for our
newsletter
Open Account Now